CK2beta promotes Pink1/Parkin-mediated MIRO1 degradation.
- Author:
Chenliang ZHANG
;
Siyue QIN
;
Chang'an JIANG
- Publication Type:Journal Article
- MeSH:
Casein Kinase II;
metabolism;
HEK293 Cells;
Humans;
Mitochondrial Proteins;
metabolism;
Parkinson Disease;
Protein Kinases;
metabolism;
Protein Transport;
Ubiquitin-Protein Ligases;
metabolism;
rho GTP-Binding Proteins;
metabolism
- From:
Journal of Biomedical Engineering
2014;31(6):1310-1315
- CountryChina
- Language:Chinese
-
Abstract:
PTEN-induced putative kinase 1 (PINK1), a Parkinson's disease (PD)-related protein, has two isoforms, the mitochondria-localized full-length isoform PINK1FL and the cytoplasm-localized short isoform PINK1-cyto. Studies have suggested that PINK1FL can selectively accumulate at the surface of damaged mitochondria and cooperate with another Parkinson's Disease-related protein PARKIN to trigger the degradation of MIRO1, a mitochondria trafficking regulator. The functions of PINK1-cyto are, however, not yet clear. To investigate the functions of PINK1-cyto, we expressed different proteins in cultured HEK293 cells by transfecting it with different plasmids, and detected the protein levels by Western blot after expressing for 24 h. We found that in cultured HEK293 cells, PINK1-cyto could also cooperate with PARKIN degrade MIRO1 in the presence of CK23, and the regulatory subunit of Casein Kinase II. Interestingly, this function of CK2P was not dependent on CK2alpha, the catalytic subunit of Casein Kinase II. We also found that CK2P could promote the direct interaction between PINK1-cyto and MIRO1 by immunocoprecipitation analysis. This result suggested that in addition to CK2alpha, CK2beta could also form a kinase complex.
